What are Corcept Therapeutics's profit margins?

Corcept Therapeutics (CORT) runs a 98.3% gross margin and a -1.1% operating margin, with a 6.2% net margin.

Where do Corcept Therapeutics's ratios come from?

Every ratio is computed from Corcept Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Corcept Therapeutics CORT Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	98.3%-0.2pp	98.3%-0.1pp	98.2%-0.2pp	98.4%-0.1pp	98.4%-0.1pp
Operating margin	-1.1%-17.2pp	5.9%-14.4pp	8.8%-14.0pp	14.2%-8.2pp	16.2%-7.1pp
Net margin	6.2%-13.4pp	13.1%-7.8pp	14.3%-8.2pp	18.7%-3.5pp	19.5%-3.0pp
EBITDA margin	-0.9%-17.2pp	6%-14.4pp	9%-13.9pp	14.4%-8.2pp	16.3%-7.1pp
Free cash flow margin	15.6%-10.2pp	18.6%-10.4pp	22%-0.5pp	25.2%+3.6pp	25.8%+2.1pp
Returns
Return on equity	7.2%-14.6pp	15%-8.8pp	16.7%-9.1pp	21.7%-3.1pp	21.8%-0.1pp
Return on assets	5.7%-12.1pp	11.9%-7.4pp	13.2%-7.4pp	17.6%-2.7pp	17.8%-0.7pp
Return on invested capital	-1.4%-23.3pp	8.2%-17.6pp	12.8%-15.6pp	20.1%-9.6pp	21.9%-10.6pp
Efficiency
Asset turnover	0.9×0.0×	0.9×0.0×	0.9×0.0×	0.9×0.0×	0.9×+0.1×
Inventory turnover	1.7×-0.7×	1.8×-0.1×	1.4×+0.2×	1.4×+0.4×	2.4×+1.5×
Liquidity
Current ratio	2.9×-0.2×	2.9×-0.4×	3.1×-0.6×	3.1×-2.5×	3.1×-2.1×
Quick ratio	2.8×-0.3×	2.9×-0.5×	3.1×-0.6×	3×-2.5×	3.1×-2.0×
Cash ratio	0.7×+0.1×	0.7×-0.2×	0.7×-0.4×	0.7×-0.6×	0.6×-0.9×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$6.11+7.1%	$5.40-9.8%	$5.29-5.8%	$5.28-1.5%	$5.70+14.4%
Valuation
Market capitalization	$4.29B-64.4%	$3.66B-30.7%	$8.76B+81.1%	$8.14B+141%	$12.05B+362%
Enterprise value	$4.19B-65.0%	$3.54B-31.3%	$8.64B+83.6%	$8.04B+147%	$11.97B+387%
Price / earnings	90.6×+0.6×	36.7×-0.7×	82.5×+48.4×	60.9×+34.1×	89.9×+67.8×
Price / sales	5.6×-12.0×	4.8×-3.0×	11.8×+4.1×	11.4×+5.4×	17.6×+12.6×
Price / book	6.7×-10.9×	5.7×-2.1×	13.9×+6.3×	12.8×+7.1×	17.6×+12.9×
EV / sales	5.4×-12.0×	4.7×-3.0×	11.7×+4.2×	11.2×+5.5×	17.5×+12.8×
Free cash flow yield	2.8%+1.3pp	3.9%+0.2pp	1.9%-1.1pp	2.2%-1.4pp	1.5%-3.3pp
Earnings yield	1.1%0.0pp	2.7%0.0pp	1.2%-1.7pp	1.6%-2.1pp	1.1%-3.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Corcept Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Corcept Therapeutics's profit margins?: Corcept Therapeutics (CORT) runs a 98.3% gross margin and a -1.1% operating margin, with a 6.2% net margin.
Where do Corcept Therapeutics's ratios come from?: Every ratio is computed from Corcept Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.